S&P Futures
4,368.00 -4.00 (-0.09%) Dow Futures
34,315.00 -22.00 (-0.06%) Nasdaq Futures
14,845.25 -17.50 (-0.12%) Russell 2000 Futures
1,797.20 -0.70 (-0.04%) Crude Oil
89.70 +0.07 (+0.08%) Gold
1,942.90 +3.30 (+0.17%)
After hours:
Chart Events
Performance Outlook
| Previous Close | 7.84 |
| Open | 7.76 |
| Bid | 7.50 x 900 |
| Ask | 8.13 x 800 |
| Day's Range | 7.49 - 7.85 |
| 52 Week Range | 6.22 - 20.71 |
| Volume | |
| Avg. Volume | 880,942 |
| Market Cap | 419.808M |
| Beta (5Y Monthly) | 0.95 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.56 |
| Earnings Date | Nov 01, 2023 - Nov 06, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.80 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for CDNA
Related Research
- CareDx, Inc.Analyst Report: Thermo Fisher Scientific Inc.Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (17%); life science solutions (38%); and lab products and services (38%).RatingFair ValueEconomic Moat2 years agoMorningstar
Business WireCareDx To Present at the 2023 Cantor Global Healthcare Conference
BRISBANE, Calif., September 19, 2023--CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Company will participate in the 2023 Cantor Global Healthcare Conference.
Business WireCareDx Advances Global Transplant Patient Care at ESOT Congress 2023
BRISBANE, Calif., September 14, 2023--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced a leading presence at the 2023 European Society for Organ Transplantation (ESOT) Congress taking place September 17-20, 2023, in Athens, Greece.
Business WireCareDx To Present at the H.C. Wainwright 25th Annual Global Investment Conference
BRISBANE, Calif., August 31, 2023--CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Company will participate in the H.C. Wainwright 25th Annual Global Investment Conference.
